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Abstract
Manifestations of Mycoplasma pneumoniae infection can range from self-limiting upper
respiratory symptoms to various neurological complications, including speech and lan-
guage impairment. But an association between Mycoplasma pneumoniae infection and
speech and language impairment has not been sufficiently explored. In this study, we aim
to investigate the association between Mycoplasma pneumoniae infection and subse-
quent speech and language impairment in a nationwide population-based sample using
Taiwan’s National Health Insurance Research Database. We identified 5,406 children with
Mycoplasma pneumoniae infection (International Classification of Disease, Revision 9,
Clinical Modification code 4830) and compared to 21,624 age-, sex-, urban- and income-
matched controls on subsequent speech and language impairment. The mean follow-up
interval for all subjects was 6.44 years (standard deviation = 2.42 years); the mean latency
period between the initial Mycoplasma pneumoniae infection and presence of speech and
language impairment was 1.96 years (standard deviation = 1.64 years). The results
showed that Mycoplasma pneumoniae infection was significantly associated with greater
incidence of speech and language impairment [hazard ratio (HR) = 1.49, 95% CI: 1.23–
1.80]. In addition, significantly increased hazard ratio of subsequent speech and language
impairment in the groups younger than 6 years old and no significant difference in the
groups over the age of 6 years were found (HR = 1.43, 95% CI:1.09–1.88 for age 0–3
years group; HR = 1.67, 95% CI: 1.25–2.23 for age 4–5 years group; HR = 1.14, 95% CI:
0.54–2.39 for age 6–7 years group; and HR = 0.83, 95% CI:0.23–2.92 for age 8–18 years
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group). In conclusion, Mycoplasma pneumoniae infection is temporally associated with
incident speech and language impairment.
Introduction
Mycoplasma pneumoniae (M. pneumoniae), belonging to the class Mollicutes, is a ubiquitous
and well-established pathogen of the respiratory tract. Manifestations of M. pneumoniae infec-
tion can range from self-limiting upper respiratory illness to severe pneumonia. Between 10%
and 20% of radiologically proven pneumonia cases in endemic periods and up to 50% of all
cases in epidemic periods are caused by M. pneumoniae [1, 2].
About 25% of M. pneumoniae infected persons may be complicated by the involvements of
various extrapulmonary systems, and the central nervous system (CNS) is the most frequently
affected [3, 4]. Within hospitalized patients with serologically confirmed M. pneumoniae infec-
tion, approximately 1–10% is associated with neurological manifestations [5]. Cerebellar syn-
drome, polyradiculitis, cranial nerve palsies, aseptic meningitis, encephalitis,
meningoencephalitis, acute disseminated encephalomyelitis, optic neuritis, diplopia, cranial
nerve palsy, ataxia, choreoathetosis, and ascending paralysis (Guillain-Barre syndrome) are
examples of neurological complications in M. pneumoniae infection [6]. More than 80% of
patients with CNS findings have prior or concomitant respiratory illness [7]. The time interval
between the onset of respiratory symptoms and neurological symptoms varies from 2 to 14
days [8, 9]. But late onset encephalitis after several days to a few weeks was also reported [5].
M. pneumoniae infections can occur in children of all ages. Many M. pneumoniae infections
are subclinical, a finding that is particularly common in children younger than 5 years of age
[10]. But age-specific attack rates for M. pneumoniae pneumonia could be observed. The rate
among children aged five to nine years was about two times for younger children and four
times for adults [11]. Within hospitalized pediatric patients with M. pneumoniae infection,
25% have neurological symptoms [12]. And 5–10% of childhood encephalitis is attributed to
M. pneumoniae [13]. Although there was a self-limited course and favorable outcome after an
acute M. pneumoniae infection, significant neurological sequelae in 45% of hospitalized pediat-
ric patients have been reported [12].
There were only two case reports of subsequent speech and language impairment after M.
pneumoniae infection in our literature review [14, 15]. To our knowledge, there is no large
scale study to explore the association between M. pneumoniae infection and speech and lan-
guage impairment. This study investigates the association between M. pneumoniae infection
and subsequent speech and language impairment in a nationwide population-based sample.
Materials and methods
Database
Data used were obtained from the Taiwan National Health Insurance Research Database
(NHIRD). The NHIRD was launched on March 1, 1995 and is maintained by the Department
of Health and the National Health Research Institutes (NHRI). It covers more than ninety-
nine per cent of the national population of Taiwan [16] and provides comprehensive patient
data, including demographic data, dates and numbers of clinical visits, dates of admission and
discharge, the names of prescribed drugs, dosages, and prescription duration, operations,
examinations, diagnostic codes in the format of the International Classification of Disease,
Revision 9, Clinical Modification (ICD-9-CM), and physician specialties: these provide
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valuable information for epidemiological study [17]. The NHRI has provided these data to sci-
entists for research purposes since 2000. In concert with the Bureau of the National Health
Insurance, the NHRI extracted a randomly sampled representative database of 1,000,000 peo-
ple from the registry of all enrolees via a systemic sampling method to form the Longitudinal
Health Insurance Database in 2005 (LHID 2005). The LHID contained all reimbursement
claims records from 1996 to 2013. There are no statistically significant differences in age, sex,
or health care costs between this sample and all enrollees [18].
Study subjects and design
For the difficult incubation and limited application of the polymerase chain reaction (PCR)
techniques for M. pneumoniae in the clinical settings, the serological diagnosis is widely used.
The sensitivity of the serological diagnosis is similar to that of the PCR methods [19]. In Tai-
wan, M. pneumoniae infection is diagnosed by clinical evaluation and serologic test results
[20], including specific IgM present or a greater than 4-fold increase in specific IgG levels in a
blood sample [21].
The study subjects were comprised of insured children under 18 years of age between 1998
and 2011. Inclusion criteria for the M. pneumoniae infection group included at least two
ambulatory claims within one year or at least one inpatient claim with a diagnosis of M. pneu-
moniae infection (ICD-9-CM code 4830). The foregoing definition is consistent with previous
research using this database [22]. Children who have diagnostic codes of developmental speech
or language disorder (ICD-9-CM codes 315.3, 315.31–39), aphasia (ICD-9-CM code 784.3),
voice and resonance disorders (ICD-9-CM codes 784.4, 784.40–49), and other speech distur-
bance (ICD-9-CM codes 784.5, 784.51–59) or received speech therapy before M. pneumoniae
infection were excluded from the analysis. A total of 5,406 children with M. pneumoniae infec-
tion were eligible. The children matching on age, sex, urban and income from the remaining
subjects as comparison group were randomly sampled at a 1:4 ratio. The process is shown in
Fig 1.
Case identification of speech and language impairment
Adult onset fluency disorder (ICD-9-CM code 307.0), developmental speech or language dis-
order (ICD-9-CM codes 315.3, 315.31–39), aphasia (ICD-9-CM code 784.3), voice and reso-
nance disorders (ICD-9-CM codes 784.4, 784.40–49), and other speech disturbance (ICD-
9-CM codes 784.5, 784.51–59) were operationalized as speech and language impairment.
Cases that had at least two ambulatory claims within one year or at least one inpatient claim
with these diagnostic codes were identified and collected for analysis. In addition, cases of
speech therapy without above-mentioned diagnostic codes were also classified as the group of
speech and language impairment.
Confounding factors
The analyses were adjusted for potential confounders which had been reported in relation to
speech and language impairment in previous studies, including preterm labor and small for
gestational age (ICD-9-CM codes 765–765.19) [23, 24], perinatal complications (ICD-9-CM
codes 760–764, 766–779 and V137) [24], autistic spectrum disorder (ICD-9-CM codes 299)
[25, 26], intellectual disability (ICD-9-CM codes 317, 318, 319) [26, 27], other disorders of the
CNS (ICD-9-CM codes 340–349) including cerebral palsy (ICD-9-CM codes 343) [28], atten-
tion deficit hyperactivity disorder (ICD-9-CM codes 314) [29], otitis media (ICD-9-CM codes
381.0–381.4 and 382) [30, 31], hearing loss (ICD-9-CM codes 389) [24, 26], and traumatic
brain injury (ICD-9-CM codes 800–804 and 850–854) [32].
Association between Mycoplasma pneumoniae infection and speech and language impairment
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Fig 1. Flow chart of data collection.
https://doi.org/10.1371/journal.pone.0180402.g001
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Statistical analysis
The distribution of demographic factors and comorbidities were compared between the M.
pneumoniae infection group and the comparison group. We used the Kaplan–Meier methods
to estimate cumulative incidences of speech and language impairment and the log-rank tests
to examine the differences. Finally, Cox proportional hazards models were used to compute
the hazard ratios accompanying 95% confidence intervals (CIs) after adjustment for age, sex,
urban, income, and other confounders. Two-tailed p value = 0.05 was considered significant.
Individuals who were deceased during the study period and/or were from the beneficiaries
register lost to follow-up were omitted from the analysis. All analyses were conducted using
SAS statistical software (Version 9.4; SAS Institute, Cary, NC, USA).
Ethics statement
The study was approved by the Institutional Review Board of Chang Gung Memorial Hospital.
Written informed consent was exempted.
Results
Characteristics of subjects
The study sample comprised 5,406 individuals with M. pneumoniae infection and 21,624 age-,
sex-, urban- and income-matched individuals ascertained from the database. The characteris-
tics are described and compared in Table 1. Compared to the comparison group, individuals
with M. pneumoniae infection had more perinatal complications, other disorders of the CNS,
otitis media, traumatic brain injury and subsequent speech and language impairment, and less
autistic spectrum disorder. The mean follow-up interval for all subjects was 6.44 years (standard
deviation = 2.42 years). Mean latency period between the initial M. pneumoniae infection and
presence of speech and language impairment was 1.96 years (standard deviation = 1.64 years).
Association between potential risk factors and risk of speech and
language impairment
As shown in Table 2, the hazard ratio of speech and language impairment in boys was higher
than the ratio in girls (hazard ratio = 2.00, 95% CI: 1.67–2.39). Compared to the children aged
eight to eighteen years, children aged from zero to three years have the highest risk (hazard
ratio = 24.25, 95% CI: 14.78–39.78), followed by the children aged 4–5 years (hazard
ratio = 11.19, 95% CI: 6.82–18.37) and the children aged 6–7 years (hazard ratio = 2.98, 95%
CI: 1.69–5.24). There were significant increased hazard ratios among the prior history of pre-
term labor and small for gestational age (hazard ratio = 2.05, 95% CI: 1.35–3.13), intellectual
disability (hazard ratio = 4.26, 95% CI: 1.91–9.51), or other disorders of the CNS (hazard
ratio = 1.97, 95% CI: 1.34–2.89).
Association between M. pneumoniae infection and risk of speech and
language impairment
Analyses of associations of interest are summarized in Table 2 and shown in Fig 2. In the fully
adjusted Cox regression model, M. pneumoniae infection was associated with a greater inci-
dence of speech and language impairment (hazard ratio = 1.49, 95% CI: 1.23–1.80) after
adjusting for age, sex, urban, income, preterm labor and small for gestational age, perinatal
complications, autistic spectrum disorder, intellectual disability, other disorders of the CNS,
attention deficit hyperactivity disorder, otitis media, hearing loss and traumatic brain injury.
Association between Mycoplasma pneumoniae infection and speech and language impairment
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Association between the age of M. pneumoniae infection and risk of
speech and language impairment
The present study also showed that the hazard ratios of subsequent speech and language
impairment were modified in different ages of M. pneumoniae infection. Compared with the
Table 1. Characteristics of M. pneumoniae infection cases and their matched controls.
Characteristic MP1 infection Non-MP1 infection P value2
N % N %
Sex
Girl 2719 50.30 10876 50.30 >0.9999
Boy 2687 49.70 10748 49.70
Age at entry (years)
0–3 967 17.89 3868 17.89 >0.9999
4–5 1734 32.08 6936 32.08
6–7 1198 22.16 4792 22.16
8–18 1507 27.88 6028 27.88
Preterm labor and small for gestational age
No 5267 97.43 21115 97.65 0.3501
Yes 139 2.57 509 2.35
Perinatal complications
No 4683 86.63 19322 89.35 <0.0001
Yes 723 13.37 2302 10.65
Autistic spectrum disorder
No 5398 99.85 21546 99.64 0.0130
Yes 8 0.15 78 0.36
Intellectual disability
No 5388 99.67 21531 99.57 0.3180
Yes 18 0.33 93 0.43
Other disorders of the CNS
No 5223 96.61 21130 97.72 <0.01
Yes 183 3.39 494 2.28
Attention deficit hyperactivity disorder
No 5313 98.28 21250 98.27 0.96
Yes 93 1.72 374 1.73
Otitis media
No 3167 58.58 15403 71.23 <0.01
Yes 2239 41.42 6221 28.77
Hearing loss
No 5361 99.17 21415 99.03 0.36
Yes 45 0.83 209 0.97
Traumatic brain injury
No 5212 96.41 21134 97.73 <0.01
Yes 194 3.59 490 2.27
Speech and language impairment
No 5254 97.19 21220 98.13 <0.01
Yes 152 2.81 404 1.87
1MP = M. pneumoniae;
2Chi-square test
https://doi.org/10.1371/journal.pone.0180402.t001
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same age groups without M. pneumoniae infection, the hazard ratio of subsequent speech and
language impairment in the groups younger than 6 years old was significantly increased, and
there was no significant difference in the groups over the age of 6 years. The hazard ratio of M.
pneumoniae infection in the age 0–3 years group, age 4–5 years group, age 6–7 years group
Table 2. Hazard ratios of factors associated with speech and language impairment via Cox regression analysis.
Variables Unadjusted hazard ratio Adjusted hazard ratio
Hazard ratio 95%CI P value Hazard ratio 95%CI P value
MP infection
Non-MP(reference) 1.00 1.00
MP 1.52 1.26–1.83 <.0001 1.49 1.23–1.8 <.0001
Sex
Girl(reference) 1.00 1.00
Boy 2.12 1.78–2.53 <.0001 2.00 1.67–2.39 <.0001
Age at entry (years)
0–3 22.93 14.05–37.43 <.0001 24.25 14.78–39.78 <.0001
4–5 10.79 6.59–17.67 <.0001 11.19 6.82–18.37 <.0001
6–7 2.98 1.69–5.25 0.0002 2.98 1.69–5.24 0.0002
8-18(reference) 1.00 1.00
Preterm labor and small for gestational age
No(reference) 1.00 1.00
Yes 2.53 1.77–3.62 <.0001 2.05 1.35–3.12 0.0008
Perinatal complications
No(reference) 1.00 1.00
Yes 1.44 1.14–1.81 0.0021 0.96 0.73–1.26 0.7675
Autistic spectrum disorder
No(reference) 1.00 1.00
Yes 1.19 0.30–4.78 0.8032 0.53 0.12–2.3 0.3937
Intellectual disability
No(reference) 1.00 1.00
Yes 3.32 1.58–6.98 0.0016 4.33 1.94–9.66 0.0004
Other disorders of the CNS
No(reference) 1.00 1.00
Yes 2.45 1.72–3.51 <.0001 1.98 1.35–2.9 0.0005
Attention deficit hyperactivity disorder
No(reference) 1.00 1.00
Yes 1.13 0.60–2.11 0.71 1.84 0.95–3.56 0.0701
Otitis media
No(reference) 1.00 1.00
Yes 1.01 0.84–1.21 0.9091 1.11 0.92–1.33 0.2813
Hearing loss
No(reference) 1.00 1.00
Yes 1.82 0.94–3.52 0.0748 1.65 0.84–3.25 0.1439
Traumatic brain injury
No(reference) 1.00 1.00
Yes 0.64 0.33–1.23 0.1789 0.83 0.43–1.62 0.5906
MP = M. pneumoniae
https://doi.org/10.1371/journal.pone.0180402.t002
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and age 8–18 years group was 1.43 (95% CI:1.09–1.88), 1.67 (95% CI: 1.25–2.23), 1.14 (95% CI:
0.54–2.39) and 0.83 (95% CI:0.23–2.92), respectively (Table 3).
Discussion
To our knowledge, this is the first study to investigate the relationship between M. pneumoniae
infection and speech and language impairment using a nationwide longitudinal dataset. The
results identified a greater risk for speech and language impairment with M. pneumoniae infec-
tion, after adjusting for age, sex, urban, income, preterm labor and small for gestational age,
perinatal complications, autistic spectrum disorder, intellectual disability, other disorders of
the CNS, attention deficit hyperactivity disorder, otitis media, hearing loss and traumatic
brain injury. In the present study, the mean latency period from initial M. pneumoniae infec-
tion to subsequent speech and language impairment was 1.96 years.
To our knowledge, there were only two case reports about speech and language impairment
after M. pneumoniae infection [14, 15]. One reported two female children of 5 and 8 years of
age with an apparent M. pneumoniae infection, and both showed symptoms of cerebellar
Fig 2. Cumulative incidence of speech and language impairment in cohorts with/without Mycoplasma
pneumoniae infection.
https://doi.org/10.1371/journal.pone.0180402.g002
Association between Mycoplasma pneumoniae infection and speech and language impairment
PLOS ONE | https://doi.org/10.1371/journal.pone.0180402 July 3, 2017 8 / 13
syndrome, including ataxia, hypotonia, dysarthric speech and dysmetria initially. An initial
brain MRI in one girl of 5-year-old was normal, but evident signs of global cerebellar atrophy
in follow-up brain MRI performed at 6 and 24 months were present. Incomplete resolution of
cerebellar dysfunction with speech problem and fine motor impairment was found three years
later. The other girl of 8-year-old displayed striking cerebellar swelling in initial brain MRI.
The follow-up brain MRI performed at two months showed normal signal in the cerebellum,
but a loss of the volume of both cerebellum hemispheres with preservation of vermis. She was
asymptomatic one year after the event [14]. Another case report was 5-year-old boy with a
confirmed M. pneumoniae infection. He was admitted due to right lower lobe pneumonia with
pleural effusion. But prolonged generalized tonic or tonic-clonic convulsion on the seventh
day was observed. Brain imaging showed bilateral thalamic lesions without striatal or white-
matter involvement. Even almost complete neurological recovery by 2 months, significant dys-
arthria was still present and persisted at 9 months [15]. Results from these case reports indi-
cated that M. pneumoniae infection was associated with speech and language impairment, but
the presence or not of such neurological impairment could not be totally judged from brain
image. Results from our study based on longitudinal, representative population-based design
provided support that previous M. pneumoniae infection is associated with incident speech
and language impairment.
Previous studies reported that several factors may be involved with speech and language
impairment, including male [24], perinatal factors [23, 24], hearing status [24, 26], medical
conditions [30, 31], multiple birth [33, 34], oral sucking habits [35], temperament [36], family
history of speech and language problems [37, 38], educational level of mother and father [39],
parental mental health [40], maternal age at birth of child [33], birth order [41, 42], and neigh-
borhood disadvantage [42, 43]. Mental handicap [26, 27], autism [25, 26], and attention deficit
hyperactivity disorder [29] were also related to speech and language impairment. The findings
in this study that boy, preterm labor and small for gestational age, intellectual disability, and
other disorders of the CNS were associated with speech and language impairment are compa-
rable with previous studies. But the results of this study that perinatal complications, autistic
spectrum disorder, attention deficit hyperactivity disorder, otitis media, hearing loss and trau-
matic brain injury were not statistically related to speech and language impairment are incon-
sistent with previous studies. Differences in the size and nature of the samples, the case
definition of speech and language impairment and the range and number of possible predictor
variables included in the analyses may be the main reasons for the observed differences in
study results [24]. Further research is needed to study the effects of factors which are inconsis-
tent with previous studies on speech and language impairment, including perinatal complica-
tions, autistic spectrum disorder, otitis media, hearing loss and traumatic brain injury.
Table 3. Hazard ratios for speech and language impairment in subgroups of different age groups of M. pneumoniae infection.
Variables Unadjusted hazard ratio Adjusted hazard ratio
Hazard ratio 95%CI P value Hazard ratio 95%CI P value
Age of MP infection (years)
0–3 1.51 1.16–1.98 0.0024 1.43 1.09–1.88 0.0109
4–5 1.68 1.26–2.23 0.0004 1.67 1.25–2.23 0.0005
6–7 1.13 0.54–2.36 0.7551 1.14 0.54–2.39 0.739
8–18 0.86 0.25–2.98 0.8074 0.83 0.23–2.92 0.769
MP = M. pneumoniae
https://doi.org/10.1371/journal.pone.0180402.t003
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Although most of the M. pneumoniae infection in children younger than 5 years of age
were subclinical [10], the influence on speech and language impairment was worthy of atten-
tion. In this study, children at the age of M. pneumoniae infection less than 6 years old have sig-
nificant risk to have subsequent speech and language impairment.
In most of the M. pneumoniae infected cases reviewed, respiratory illness are usually mild
and has preceded or coincided with the CNS findings [5]. And the development of several neu-
rological findings is indicative of focal or diffuse CNS injury. The definite etiopathogenic
mechanism is unknown. Several pathogenic theories have been put forth in recent years,
including direct neuroinvasion, neurotoxin elaboration, hypercoagulable state and infection
leading to immune dysfunction, such as autoantibodies production [5, 44–46]. It is possible
that multiple mechanisms may be occurring simultaneously. For our study, immune complex
mediated injury may be one of the pathogenic mechanisms. Through this mechanism, M.
pneumoniae derived antigenic elements may act as molecular mimics and initiate complex
immune reactions which subsequently generate neurological injury. A variety of autoantibod-
ies production, such as antibodies against the mitotic spindle apparatus, the centriole, cardioli-
pin, smooth muscle cells, and lung, liver, and brain antigens (e.g. anti-neuronal antibodies)
and IgM-class cold agglutinins have been reported after M. pneumoniae infection [47–51].
Another possible mechanism is the hypercoagulable state which could result in neurological
injury from intravascular coagulation and thromboembolic phenomena of the cerebral vascu-
lature. And immune mediated vascular injury and the development of a vasculitis could fur-
ther contribute to such effects [52, 53]. It requires further empirical study to explore the
putative mechanism of M. pneumoniae -induced immune response and its influence on speech
and language impairment.
Strength and limitations
The large, nationally representative sample population and longitudinal dataset are key
strengths in this study. But there are also several limitations. First, we could not rule out the
possible influence of other previously proposed confounding variables not assessed and
adjusted for, such as multiple birth, oral sucking habits, temperament, family history of speech
and language problems, educational level of mother and father, parental mental health, mater-
nal age at birth of child, birth order, and neighborhood disadvantage. Second, the period of fol-
low-up is insufficient to confirm all possible cases. Speech and language impairment may
manifest after the end of the study period in some subjects. Third, the diagnosis of M. pneumo-
niae infection and speech and language impairment was established by board physicians and
registered in the database. Differences between healthcare providers in their diagnosis of M.
pneumoniae infection and speech and language impairment cannot be controlled for. How-
ever, the accuracy of disease diagnoses in national health insurance system could reach up to
85% [54]. Fourth, because of lack of brain imaging data in this study, it could not explore
whether the emergence of speech and language impairment was due to brain damage after M.
pneumoniae infection or not.
Conclusions
M. pneumoniae infection is temporally associated with incident speech and language
impairment. Clinicians should advise parents of children with M. pneumoniae infection to
attend to symptoms that are associated with the development of speech and language
impairment, especially when the child is less than 6 years old.
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